Showing results (511-520 of 635) with videos related to

Sort By:
Pageof 64
JACC. Heart Failure|April 4, 2024
Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVERJawad H Butt, Pardeep S Jhund, Kieran F Docherty, et al.
JAMA Cardiology|January 24, 2024
Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER TrialOrly Vardeny, Akshay S Desai, Pardeep S Jhund, et al.
Lancet (London, England)|August 30, 2021
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trialJoAnn Lindenfeld, Michael R Zile, Akshay S Desai, et al.
Journal of the American College of Cardiology|October 1, 2024
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF TrialAkshay S Desai, Muthiah Vaduganathan, Brian L Claggett, et al.
European Journal of Heart Failure|September 20, 2024
In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trialMaria A Pabon, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation|October 13, 2023
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER TrialJohn W Ostrominski, Muthiah Vaduganathan, Senthil Selvaraj, et al.
European Journal of Heart Failure|February 20, 2021
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trialJoão Pedro Ferreira, Brian L Claggett, Jiankang Liu, et al.
European Journal of Heart Failure|August 26, 2020
Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HFSenthil Selvaraj, Brian L Claggett, Marc A Pfeffer, et al.
European Journal of Heart Failure|May 21, 2023
Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA-HFSafia Chatur, Toru Kondo, Brian L Claggett, et al.
JACC. Heart Failure|August 20, 2025
Achieved Ejection Fraction and Effects of Dapagliflozin in Heart Failure With Improved Ejection FractionSara R O Siqueira, Maria A Pabon, Muthiah Vaduganathan, et al.
Pageof 64